I looked at it and looked at it and looked at it, and I never bought it. And I'm the guy that buys everything. 

OMGA and SHOT also rebounding pretty well. 

In the junior biotech area, hit targets on CLRB and PYXS. Bought KURA on its dip and VVOS, trying to rebound from a 90% fall. 

CLSK has broken above its 50 SMA and 21 EMA also.

PYXS on a tear on a big volume jump.

My quick read is that it is 'shrooms, not acid. 

I had been looking for a buy opportunity and bought AH yesterday on the KISS buy, something I often do.

I don't know how the Mega 10 grew to 37, but glad to see one of my favorites, ACMR, on there. 

Since I'm using a buy stop limit, I'm not buying the gap up, but a partial fill of the gap. I'd be interested to hear how far into the day you would consider to be valid confirmation. 

Raised targets, what else?

Re trade ideas, I have URA and HRTX triggering. HRTX is OK so far, but URA reversed a little lower, however still above the 9 EMA. 

SSNT recovering after a 50% pullback. One of my leftover long pieces that looks like a good short right here is AMPH.

Bought RUM yesterday in the 4's. Just sold half at 6.80. I know it pales compared to RVSN, but nice compensation. This showed up on the Finviz list and I looked at it as a good follow-on play to DWAC. 

ESOA is a small cap energy stock that broke out today.

VIST is another with good relative strength. And WFRD has held up well through all of the ups and downs. 

It's been a great one, along with fellow cybersecurity stock ZS.

Go Pakis! I'll take some help against the evil forces of the world.

Hi Matt, we've been missing numbers in the profit column on the STS tables the last couple of days. 

DRV outperforming SRS today. Not sure about the leverage of SRS, but DRV is -3x.

There are still a few. Matt says use at your own risk, but sometimes they have done well, like LABD a while back.